Europe Anticoagulants Market Size & Outlook, 2023-2030

The anticoagulants market in Europe is expected to reach a projected revenue of US$ 18,569.5 million by 2030. A compound annual growth rate of 8.2% is expected of Europe anticoagulants market from 2024 to 2030.
Revenue, 2023 (US$M)
$10,717.9
Forecast, 2030 (US$M)
$18,569.5
CAGR, 2024 - 2030
8.2%
Report Coverage
Europe

Europe anticoagulants market highlights

  • The Europe anticoagulants market generated a revenue of USD 10,717.9 million in 2023.
  • The market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
  • In terms of segment, novel oral anticoagulants (noacs) was the largest revenue generating drug category in 2023.
  • Heparin and Low Molecular Weight Heparin (LMWH) is the most lucrative drug category segment registering the fastest growth during the forecast period.
  • Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 10,717.9 million
Market revenue in 2030USD 18,569.5 million
Growth rate8.2% (CAGR from 2023 to 2030)
Largest segmentNovel oral anticoagulants (noacs)
Fastest growing segmentHeparin and Low Molecular Weight Heparin (LMWH)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNovel Oral Anticoagulants (NOACs), Vitamin K Antagonist, Direct Thrombin Inhibitors, Heparin and Low Molecular Weight Heparin (LMWH)
Key market players worldwideAspen Group Inc, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, Sanofi SA, Bayer AG, Boehringer Ingelheim, Daiichi Sankyo Co Ltd, Johnson & Johnson, Eisai Co Ltd


Other key industry trends

  • In terms of revenue, Europe region accounted for 30.8% of the global anticoagulants market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 9,468.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anticoagulants Market Companies

Name Profile # Employees HQ Website

Europe anticoagulants market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulants market will help companies and investors design strategic landscapes.


Novel oral anticoagulants (noacs) was the largest segment with a revenue share of 57.26% in 2023. Horizon Databook has segmented the Europe anticoagulants market based on novel oral anticoagulants (noacs), vitamin k antagonist, direct thrombin inhibitors, heparin and low molecular weight heparin (lmwh) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe anticoagulants market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe anticoagulants market databook

  • Our clientele includes a mix of anticoagulants market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe anticoagulants market , including forecasts for subscribers. This continent databook contains high-level insights into Europe anticoagulants market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe anticoagulants market size, by country, 2018-2030 (US$M)

Europe Anticoagulants Market Outlook Share, 2023 & 2030 (US$M)

Europe anticoagulants market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more